Among the breast cancer cohort, there was no significant difference in mean baseline plasma S1P levels between premenopausal patients and postmenopausal patients (1163.6 versus 1266.9 pmol/mL, p = 0.13). This evidence concerns the gene MBTPS1 and breast carcinoma.